Technology

Evofem

$2.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (+0.71%) Today
+$0.12 (+4.24%) As of 11:07 AM UTC after-hours

Why Robinhood?

You can buy or sell Evofem and other stocks, options, and ETFs commission-free!

About EVFM

Evofem Biosciences, Inc. Common Stock, also called Evofem, is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate) a hormone-free vaginal gel and EVO100 an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA. The listed name for EVFM is Evofem Biosciences, Inc. Common Stock.

CEO
Saundra L. Pelletier
Employees
53
Headquarters
San Diego, California
Founded
2007
Market Cap
221.89M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.80M
High Today
$2.92
Low Today
$2.75
Open Price
$2.78
Volume
2.34M
52 Week High
$7.21
52 Week Low
$1.91

Collections

EVFM Earnings

-$0.95
-$0.63
-$0.32
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

HRTG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure